entertainment -WSS

entertainment

author：Wikipedia 2025-09-28 21:57:01 - browse：7972

Chief executive officer of Sanofi Paul Hudson, wearing glasses, speaks into a mic — pharma coverage from STAT — Sanofi CEO Paul Hudson Carolyn Kaster/AP

LONDON — Sanofi CEO Paul Hudson on Wednesday defended his company’s recent moves to abandon future profit guidance and up its investment in its own research programs, arguing that the dramatically negative market response didn’t reflect the potential rewards that could stem from the plan.

“Would I have liked the stock market reaction to be more generous? Of course,” Hudson said at a Financial Times event in London. “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Sanofi unveiled its R&D plans late last month as it announced its third-quarter performance and said that it was spinning out its consumer health division. As the company said it was going to spend more money on research, it also withdrew earnings outlooks for 2025. Company executives have argued that this was the moment — when Sanofi has a strong pipeline and isn’t facing patent expirations for years — to increase its R&D resources, even at the expense of short-term profits.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Beware reading your test results before your doctor does

WSS

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

Biotech stock slump in 2023: awaiting the turnaround

CDC advisers recommend seasonal use of Pfizer RSV shot

FDA panel to weigh approval of NurOwn, controversial ALS drug

Undocumented workers face uncertainty as immigration law takes effect in Florida

STAT wants to know your pick for a great summer read or listen

entertainment

entertainment

hotspot

Cancer drug shortages should be causing more outrage

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Guidelines to prevent youth baseball injuries need more muscle

Use doctors trained outside the U.S. to ease the physician shortage

At least 13 dead in Texas as scorching temps continue

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

CDC advisers recommend seasonal use of Pfizer RSV shot

Psychedelics group wrestles with new pharma identity

Skip the lead apron during X

knowledge

Microbiome research is starting to find links to chronic diseases

Senators: Long

Thermo Fisher plant for manufacturing gene therapies to expand

'Screen and refer' systems are hurting patients

EpiPen alternative approval delay highlights citizen petition issue

Drug for rare kidney disease narrowly misses mark in clinical trial

explore

leisure time

entertainment

entertainment